| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
01.10.2026 18:53:03
|
Holding(s) in Company
|
Molten Ventures Plc (GROW)
TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BY7QYJ50 Issuer Name MOLTEN VENTURES PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name BlackRock, Inc. City of registered office (if applicable) Wilmington Country of registered office (if applicable) USA 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached 29-Sep-2026 6. Date on which Issuer notified 30-Sep-2026 7. Total positions of person(s) subject to the notification obligation
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached 8A. Voting rights attached to shares
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
9. Information in relation to the person subject to the notification obligation 2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
10. In case of proxy voting Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
If date does not apply, explain below
11. Additional Information BlackRock Regulatory Threshold Reporting Team 12. Date of Completion 30th September 2026 13. Place Of Completion 12 Throgmorton Avenue, London, EC2N 2DL, U.K. Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. View original content: EQS News |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ISIN: | GB00BY7QYJ50 |
| Category Code: | HOL |
| TIDM: | GROW |
| LEI Code: | 213800IPCR3SAYJWSW10 |
| Sequence No.: | 445198 |
| EQS News ID: | 2409144 |
| End of Announcement | EQS News Service |
|
|
Trading Signals: Coca-Cola - Die Rallye hat noch Sprudel
Der Brausekonzern beweist, dass auch defensive Konsumwerte für prickelnde Kursgewinne gut sind. Überraschend starke Quartalszahlen, eine erhöhte Gewinnprognose und optimistische Analysten sprechen für eine Fortsetzung des Aufwärtstrends. Die 100-Dollar-Marke ist zum Greifen nahe.
Weiterlesen!Nachrichten zu Draper Esprit PLC
|
26.10.26 |
Half Year Trading Update (EQS Group) | |
|
01.10.26 |
Holding(s) in Company (EQS Group) | |
|
18.09.26 |
Holding(s) in Company (EQS Group) | |
|
15.09.26 |
Holding(s) in Company (EQS Group) | |
|
14.09.26 |
Holding(s) in Company (EQS Group) | |
|
14.09.26 |
Holding(s) in Company (EQS Group) | |
|
14.09.26 |
Holding(s) in Company (EQS Group) | |
|
10.09.26 |
Holding(s) in Company (EQS Group) |
Novartis, Sandoz und Eli Lilly im Vergleich: François Bloch und Olivia Hähnel ordnen im aktuellen BX Morningcall Umsatzentwicklung, EBIT, EBIT-Margen, Eigenkapitalrendite, Dividenden und Kursperformance ein. Im Fokus stehen die unterschiedlichen Geschäftsmodelle, Erwartungen und Risiken der drei Pharmakonzerne.
Das Gespräch behandelt Novartis nach den angesprochenen Quartalszahlen, Sandoz mit Biosimilars und Nachahmerprodukten sowie Eli Lilly mit hohen Wachstumserwartungen.
Themen im Video:
• Novartis: Quartalszahlen, Margen, Dividende, Performance und CEO-Frage
• Sandoz: Umsatzwachstum, Biosimilars, Margen und Wettbewerb
• Eli Lilly: Wachstumserwartungen, Profitabilität, Dividendenrendite und Bewertungsrisiken
• BX Musterportfolio: Portfolio-Perspektive, Risikomanagement und Rebalancing
https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside ETF
Aktien in diesem Artikel
| Draper Esprit PLC | 8.25 | -1.20% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Vor EZB-Zinsentscheid: SMI mit Rekordhoch -- DAX fester -- Asiens Börsen letztlich mehrheitlich tiefer - Nikkei starkDer heimische sowie der deutsche Aktienmarkt präsentieren sich am Donnerstag mit Gewinnen. An den Börsen in Fernost ging es am Donnerstag uneinheitlich zu.